multiple myeloma button

Share

    


In This Section

Home / Learn / Multiple Myeloma

Multiple Myeloma

Multiple myeloma, also known as myeloma, is the third most common hematologic cancer (cancer of the blood). However, compared to more frequently occurring cancers (e.g., breast, prostate, lung, and colorectal cancers), multiple myeloma is relative rare and accounts for only 1.6 percent of diagnoses each year. For 2018, the American Cancer Society estimates that 30,770 new cases of myeloma will be diagnosed in the U.S.1 Due to the less common occurrence of multiple myeloma, providers are less likely to diagnosis and treat these patients on a regular basis. 

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA: Cancer J Clin. 2018;68:7-30.

Featured Programs

Advances in Multiple Myeloma and ALL ECHO Clinic

 

ACCC is committed to help ensure access to recommended care for patients who receive treatment for multiple myeloma or acute lymphoblastic leukemia (ALL) through a partnership with the American Cancer Society and Project ECHO. The educational focus will be on bringing the latest content knowledge and best practices in the treatment of these hematological cancer patients to your cancer care team.

Participation in the TeleECHO Clinic is free. The clinics will convene by videoconference each month.

Each session of the Advances in Multiple Myeloma and Acute Lymphoblastic Leukemia TeleECHO Clinic includes a short talk on a topic related to the treatment of these hematological cancer patients and review of patient cases submitted by spoke site participants. Topics include:

  • Understanding minimal residual disease (MRD) as a Biomarker
  • Current standard of care/guidelines (including stem cell transplants)
  • New and emerging therapies, clinical trials and shared decision-making
  • Managing symptoms and side effects (possible multiple sessions)
  • Multidisciplinary care and care transitions (patient co-management)

This program will provide specialty multiple myeloma and acute lymphoblastic leukemia cancer treatment information and training to healthcare providers to help build their capacity to provide high-quality, best-practice care locally for patients and thereby increase access to care across the nation.

Contact Monique Dawkins, EdD, MPA, for information on how to participate. 

More ECHO Clinics Launching Soon

In 2020, the American Cancer Society and Project ECHO partnership will also bring TeleECHO sessions focused on Colorectal Cancer and Bone Health in Patients with Breast and Prostate cancer. Information on the Colorectal ECHO TeleClinics is available here. Information on the Bone Health ECHO clinics will be available soon. 

Multidisciplinary Multiple Myeloma Care

Guided by an expert Advisory Committee, this ACCC education project aims to support the multidisciplinary cancer care team in diagnosing, testing, and treating patients with multiple myeloma. This project seeks to:

  • raise awareness about provider education needs related to this patient population;
  • provide vetted, designated resources for unmet education needs; and
  • establish a network of multidisciplinary team members with interest and expertise in caring for patient with multiple myeloma.

The ACCC Multidisciplinary Multiple Myeloma (MM) Visiting Experts Workshop Series offers an exceptional opportunity for ACCC Cancer Program Members to host a full-day multiple myeloma-focused workshop on-site at your facility. This expert-led education session is designed to benefit the entire multidisciplinary oncology care team.

Learn More

ACCC's publication, Multidisciplinary Multiple Myeloma Care: Models of Effective Care Deliveryprovides a summary of recent updates in myeloma management, along with profiles that describe how three cancer programs—a community-based comprehensive program, an academic medical center, and an NCI-designated program—are delivering multidisciplinary care to this patient population. Plus, access an on-demand lecture series covering topics such effective management of patients with high-risk profiles, summary of guideline recommendations for prevention and management of skeletal-related events, and the importance of the multidisciplinary, team-based approach to care.

Learn More

 

Transplant Treatment Path

The ACCC educational initiative, The Transplant Treatment Path: Optimizing Patient-Centered Care for ASCT in Multiple Myeloma aimed at improving provider communication to optimize the treatment of multiple myeloma patients in the community cancer center pre- and post-autologous stem cell transplant (ASCT).
Learn More

In the News